Frontiers in Oncology (Feb 2022)

A Modified Microscopic-Endoscopic Bilateral Transseptal Approach for Pituitary Adenomas: Comparisons of Nasal Outcome and Quality of Life Using the Microscopic Transnasal Approach

  • Junjie Zhong,
  • Junjie Zhong,
  • Junjie Zhong,
  • Junjie Zhong,
  • Junjie Zhong,
  • Yanfang Gu,
  • Yanfang Gu,
  • Yanfang Gu,
  • Yanfang Gu,
  • Yanfang Gu,
  • Jie Zheng,
  • Jie Zheng,
  • Jie Zheng,
  • Jie Zheng,
  • Jie Zheng,
  • Bojie Yang,
  • Bojie Yang,
  • Bojie Yang,
  • Bojie Yang,
  • Bojie Yang,
  • Zengxin Qi,
  • Zengxin Qi,
  • Zengxin Qi,
  • Zengxin Qi,
  • Zengxin Qi,
  • Tianwen Li,
  • Tianwen Li,
  • Tianwen Li,
  • Tianwen Li,
  • Tianwen Li,
  • Chao Shen,
  • Chao Shen,
  • Chao Shen,
  • Chao Shen,
  • Chao Shen,
  • Chao Shen,
  • Zhifeng Shi,
  • Zhifeng Shi,
  • Zhifeng Shi,
  • Zhifeng Shi,
  • Zhifeng Shi,
  • Zhifeng Shi

DOI
https://doi.org/10.3389/fonc.2022.778704
Journal volume & issue
Vol. 12

Abstract

Read online

ObjectivesIn this study, we introduced a novel modified microscopic-endoscopic bilateral transseptal approach for pituitary adenoma resection to minimize surgery-related nasal injury. We also retrospectively compared comprehensive nasal outcomes and quality of life between the microscopic transnasal approaches.MethodsPatients with pituitary adenomas who underwent modified microscopic-endoscopic bilateral transseptal or microscopic transnasal approaches were assessed for olfactory function and quality of life using the Sniffin’ Sticks test, the Sino-Nasal Outcome Test-22 (SNOT-22), the SF-36, the anterior skull base (ASK) nasal inventory, and the subjective visual analog scale (VAS) before and 1 and 3 months after surgery. A nasal endoscopy procedure was also performed to evaluate structure abnormalities at 1 and 3 months after surgery.ResultsFifty-eight patients who underwent either modified microscopic-endoscopic bilateral transseptal (35 patients) or microscopic transnasal (23 patients) surgery were consecutively enrolled. Patients who underwent either transnasal approach experienced similar surgical complications, except for intraoperative cerebrospinal fluid leakage (43.5% vs 14.3% for modified microscopic-endoscopic bilateral transseptal or microscopic transnasal approach, respectively; p = 0.013). Patients who underwent the two approaches fully recovered according to the SF-36, SNOT-22, VAS, and Sniffin’ Sticks surveys, but not ASK scores, 3 months post-operatively. There was no significant difference in nasal endoscopy outcome at 3 months follow-up between the two approaches.ConclusionsThe modified microscopic-endoscopic bilateral transseptal approach showed largely similar nasal mucosa protective outcomes to those of the microscopic transnasal approach for pituitary adenoma surgery. After pituitary adenoma resection using the modified approach, patients’ postoperative olfactory function, nasal structure, and quality of life can be restored to preoperative status within 3 months.

Keywords